Stocks Listing
BAX

Baxter International Inc.

Share
BAX
$56.00 0.53%Last Updated Nov 25 2022 09:15 PM
1D Low / 1D High
Low:$55.70
High:$56.73
1D
0.53%
5D
1.82 %
30D
1.94 %
BulletPurple
Market Cap
$28,230,774,784
0.53 %
28.2 B
BulletBlue
Volume 1D
2,083,710
-
2.1 M
BulletOrange
Circulating Supply
504,120,978 BAX
504.1 M

Price Chart

1D
5D
1M
6M
YTD
1Y
MAX
About

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies. It also provides biological products and medical devices, and surgical hemostat and sealant products used in surgical procedures for hemostasis, tissue sealing, and adhesion prevention; premixed and oncology drug platforms, inhaled anesthesia and critical care products, and pharmacy compounding services; and generic injectable pharmaceuticals. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was founded in 1931 and is headquartered in Deerfield, Illinois.

Read More

Historical data

1D
5D
1M
6M
1Y
MAX
Day
Open - Close
Low/High
Volume
Market Cap
Show More
Market Status
Opened
NYQ
New York Stock Exchange
USA
Closes in
4 hours, 12 minutes
Working Hours
Mon-Fri, 02:30 PM - 09:00 PM
Timezone
GMT+0